Published in Health and Medicine Week, March 8th, 2004
Furthermore, patients who were hospitalized during their treatment with Risperdal Consta had significantly shorter hospital stays than before treatment with the new therapy. The reduction in both the number and duration of hospitalizations associated with the use of Risperdal Consta resulted in substantial cost savings for the Swedish health care...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week